Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 6, Number 5—October 2000

Dispatch

Double infection with a Resistant and a Multidrug-Resistant Strain of Mycobacterium tuberculosis

Stefan Niemann, Elvira Richter, Sabine Rüsch-GerdesComments to Author , Max Schlaak, and Ulf Greinert
Author affiliations: Forschungszentrum Borstel, Borstel, Germany

Main Article

Figure

Spoligotypes and drug-resistance patterns of isolates of patient's first (1 and 2, type I) and second culture-positive phase (3-8, type II). The spoligotypes of the first two cultures differ clearly from those of the latter ones. The eight isolates were obtained on the following dates: 1, February 28, 1996; 2, March 17, 1996; 3, June 6, 1996; 4, July 12, 1996; 5, March 15, 1997; 6, April 25, 1997; 7, February 18, 1998; and 8, June 23, 1998. H, isoniazid; S, streptomycin; R, rifampin; E, ethambut

Figure. Spoligotypes and drug-resistance patterns of isolates of patient's first (1 and 2, type I) and second culture-positive phase (3-8, type II). The spoligotypes of the first two cultures differ clearly from those of the latter ones. The eight isolates were obtained on the following dates: 1, February 28, 1996; 2, March 17, 1996; 3, June 6, 1996; 4, July 12, 1996; 5, March 15, 1997; 6, April 25, 1997; 7, February 18, 1998; and 8, June 23, 1998. H, isoniazid; S, streptomycin; R, rifampin; E, ethambutol; Rb, rifabutin; Pt, protionamide; Z, pyrazinamide; Pa, p=aminosalicylic acid; Am, amikacin. Borderline results are displayed in brackets.

Main Article

TOP